These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5075911)

  • 1. Immunity to influenza.
    Stuart-Harris CH
    J Infect Dis; 1972 Oct; 126(4):466-8. PubMed ID: 5075911
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.
    Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA
    J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093
    [No Abstract]   [Full Text] [Related]  

  • 3. The molecular epidemiology of influenza.
    Kilbourne ED
    J Infect Dis; 1973 Apr; 127(4):478-87. PubMed ID: 4121053
    [No Abstract]   [Full Text] [Related]  

  • 4. An outbreak of an influenza type A variant in a closed population: The effect of homologous and heterologous antibody on infection and illness.
    Greenberg SB; Couch RB; Kasel JA
    Am J Epidemiol; 1974 Sep; 100(3):209-15. PubMed ID: 4479059
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience in using the HIR modified by the addition of antisera to IgG, IgM and IgA for detecting anti-influenzal antibodies in respiratory tract discharge].
    Gennad'eva TIa; Khazenson LB; Bichurina MA
    Tr Inst Im Pastera; 1976; 47():78-84. PubMed ID: 1052587
    [No Abstract]   [Full Text] [Related]  

  • 6. Influenza and influenza immunization.
    Fulginiti VA
    Ariz Med; 1976 Dec; 33(12):999-1006. PubMed ID: 797353
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of "Hong Kong" vaccine in preventing "England" variant influenza A in 1972.
    Stiver HG; Graves P; Eickhoff TC; Meiklejohn G
    N Engl J Med; 1973 Dec; 289(24):1267-71. PubMed ID: 4127183
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody against influenza A2 virus neuraminidase in human sera.
    Schild GC
    J Hyg (Lond); 1969 Jun; 67(2):353-65. PubMed ID: 5256462
    [No Abstract]   [Full Text] [Related]  

  • 9. Nasal and circulating antibody responses to influenza vaccination and their importance in resistance to infection.
    Tyrrell DA; Buckland RA; Schild GC; Freestone DS; Chinn S; Slepushkin AN
    Postgrad Med J; 1973 Mar; 49(569):200-2. PubMed ID: 4802537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the quantitative rate of the immunoglobulins G, A, M, and D, of hemagglutination inhibiting antibodies, of transferrin, coeruloplasmin, alpha2-macroglobulin, and CRP in children with influenza A2/Hong Kong (author's transl)].
    Wiedermann D; Wiedermannová D; Novotná D; Oravcová V
    Zentralbl Bakteriol Orig A; 1974; 229(2):141-9. PubMed ID: 4155859
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibodies against influenza--individual and group immunity (author's transl)].
    Farník J; Bruj J; Skocil V
    Cesk Epidemiol Mikrobiol Imunol; 1980 Jan; 29(1):33-8. PubMed ID: 6445784
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man.
    Couch RB; Douglas RG; Fedson DS; Kasel JA
    J Infect Dis; 1971 Nov; 124(5):473-80. PubMed ID: 5000515
    [No Abstract]   [Full Text] [Related]  

  • 13. [Persistence of anti-V hemagglutination-inhibiting antibodies and complement-fixing antibodies induced by administration of inactivated influenza vaccines].
    Profeta ML
    Ann Sclavo; 1972; 14(2):145-58. PubMed ID: 4669354
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of the transplacental transfer of anti-influenza immunoglobulins, nonspecific antihemagglutinins, "cofactor" and the determination of their age-related dynamics in children].
    Shuratov IKh; Kosiakov PN
    Vopr Virusol; 1974; (4):426-31. PubMed ID: 4439852
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antibody determination following influenza vaccination].
    Wegmann A
    Ther Umsch; 1972 Dec; 29(12):747-9. PubMed ID: 4639117
    [No Abstract]   [Full Text] [Related]  

  • 16. Inactivated influenza vaccines. 2. Laboratory indices of protection.
    Dowdle WR; Coleman MT; Mostow SR; Kaye HS; Schoenbaum SC
    Postgrad Med J; 1973 Mar; 49(569):159-63. PubMed ID: 4803439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza virus split vaccines. Effect of priming infection on serologic response in humans.
    Niculescu IT; Zilisteanu E; Cretescu L; Matepiuc M; Dumitrescu R; Oprescu E; Bodnar C; Cuteanu I; Vlad A; Mogos A
    Arch Roum Pathol Exp Microbiol; 1979; 38(2):147-54. PubMed ID: 262510
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of partial immunity to influenza by a neuraminidase-specific vaccine.
    Couch RB; Kasel JA; Gerin JL; Schulman JL; Kilbourne ED
    J Infect Dis; 1974 Apr; 129(4):411-20. PubMed ID: 4593871
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the postvaccination level of influenza antibodies by means of the radial immunodiffusion and hemagglutination inhibition reactions].
    Vavilova IuG; Gorev NE; Zykov MP
    Vopr Virusol; 1976; (2):158-61. PubMed ID: 820079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity against parainfluenza-3 virus in cattle: anti-neuraminidase activity in serum and nasal secretion.
    Morein B; Höglund S; Bergman R
    Infect Immun; 1973 Oct; 8(4):650-6. PubMed ID: 4355138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.